New - European Medical Journal

Continue

News

Nephrology
27 Nov 2020

Sotagliflozin Associated with Reduced Risk of Cardiovascular Events

SOTAGLIFLOZIN is a sodium–glucose cotransporter 2 (SGLT2) inhibitor that may reduce the risk of urgent medical care for heart failure, hospitalisation…
Diabetes
20 Nov 2020

Gut Microbiota Molecule Linked to Reduced Metformin Response

DYSBIOSIS of the gut microbiota is now recognised to have significant effects on the health of an individual, with changes in metabolism linked to diabet…
Diabetes
20 Nov 2020

Diabetes and Hypertension May Increase risk of Neurological Complications in Patients with COVID-19

NEUROLOGICAL complication risk in patients with coronavirus disease (COVID-19) may be increased in those with a history of hypertension and Type 2…
Neurology
13 Nov 2020

Kvβ1 Potassium Channel Subunit Identified as a Control Point for Learning and Memory

ELECTRICAL signals in the brain regulated by a ‘molecular volume knob’ aid with learning and memory, according to a new study at Dartmouth College…
Neurology
13 Nov 2020

Could Somatostatin be the Elusive Alzheimer’s Disease Drug?

AMYLOID-β (Aβ) is the main component of the amyloid aggregates found in the brains of individuals with Alzheimer’s disease. Many drugs in clinical trials…
Innovations
12 Nov 2020

Data Science Pathway to Advance AI in Radiology

A recently developed data science pathway for 4th-year radiology residents could be preparing these clinicians for future technology use.
Gastroenterology
12 Nov 2020

Almost 20% of COVID-19 Patients Present with Only Gastrointestinal Symptoms

A review of published academic studies has found that almost 20% of COVID-19 patients may only display gastrointestinal symptoms.
Allergy & Immunology
6 Nov 2020

How Long Do Antibodies Persist After COVID-19?

Although there was variation between individual patients’ antibody levels, the researchers found the overall trend of rapid reduction to be consistent.